Trial Profile
Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2012
Price :
$35
*
At a glance
- Drugs Ticarcillin/clavulanic acid (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 13 Nov 2012 Actual initiation date Sep 2010 added as reported by ClinicalTrials.gov.
- 13 Nov 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 04 Oct 2012 Planned End Date changed from 1 Dec 2012 to 31 Dec 2012 as reported by ClinicalTrials.gov.